Fabio Sagebin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fabio Sagebin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Antonio H. Frangieh
Mary & Steve Wen Cardiovascular Division, University of California Irvine, Irvine, CA 92697, USA
2 shared publications - Christina M. Mansour
Mary & Steve Wen Cardiovascular Division, University of California Irvine, Irvine, CA 92697, USA
2 shared publications - David M. Donaldson
Division of Cardiology, University of California, Irvine, 101 The City Drive South Suite 407, Orange, CA 92868, USA
1 shared publication - Kevin S. Tang
Department of Medicine, University of California-Irvine Health, Orange, California, USA
1 shared publication - Long-Co L. Nguyen
Mary & Steve Wen Cardiovascular Division, University of California Irvine, Irvine, CA 92697, USA
1 shared publication - Mark W. Abdelnour
Mary & Steve Wen Cardiovascular Division, University of California Irvine, Irvine, CA 92697, USA
1 shared publication
Latest Publications
- Open Access
- 19 April 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (4) , 172
Surgical and Transcatheter Tricuspid Valve Interventions: An Electrophysiology-Focused Review
Increasing recognition of the clinical impact of isolated tricuspid regurgitation has led to rapid expansion of surgical and transcatheter tricuspid valve interventions. Given the close anatomic relationship between the tricuspid valve and the atrioventricular conduction system, both surgical and transcatheter approaches carry a significant risk of new conduction disturbances and permanent pacemaker implantation. A three-dimensional understanding of the atrioventricular conduction axis is essential to anticipate and mitigate these complications. This review provides a comprehensive overview of conduction system anatomy and physiology in the context of tricuspid valve interventions, highlighting the mechanisms underlying procedure-related conduction abnormalities. We also discuss contemporary management strategies, including approaches to pre-existing transvalvular leads, valve-sparing pacing alternatives, and the evolving role of electrophysiologists within the multidisciplinary heart team.
- 19 April 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (4) , 172
Open AccessSurgical and Transcatheter Tricuspid Valve Interventions: An Electrophysiology-Focused Review
Increasing recognition of the clinical impact of isolated tricuspid regurgitation has led to rapid expansion of surgical and transcatheter tricuspid valve interventions. Given the close anatomic relationship between the tricuspid valve and the atrioventricular conduction system, both surgical and transcatheter approaches carry a significant risk of new conduction disturbances and permanent pacemaker implantation. A three-dimensional understanding of the atrioventricular conduction axis is essential to anticipate and mitigate these complications. This review provides a comprehensive overview of conduction system anatomy and physiology in the context of tricuspid valve interventions, highlighting the mechanisms underlying procedure-related conduction abnormalities. We also discuss contemporary management strategies, including approaches to pre-existing transvalvular leads, valve-sparing pacing alternatives, and the evolving role of electrophysiologists within the multidisciplinary heart team.
- Open Access
- 17 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2269
Lifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making
Background: The landscape surrounding aortic stenosis continues to evolve as transcatheter aortic valve replacement (TAVR) is increasingly performed in younger and lower-risk patients who are likely to outlive their index prosthesis. With the rapid evolution in management of aortic stenosis, treatment has shifted from a single-procedure paradigm toward a lifetime strategy that anticipates future reinterventions. Therefore, having a foundational understanding and a thoughtful strategy when selecting the index procedure is paramount. Objectives: The objectives of this review article are to review contemporary evidence and provide a structured framework for lifetime management of severe AS. We focus on optimizing index valve selection and planning durable, safe pathways for subsequent reinterventions. Conclusions: Lifetime management of aortic stenosis requires a forward-looking, patient-centered Heart Team approach that extends beyond immediate procedural success. Strategic selection of the index valve intervention is crucial, and this is guided by anatomy, life expectancy, comorbidities, patient preference, and future reintervention feasibility. Together, these factors are essential to optimize long-term outcomes. As treatment paradigms continue to evolve, anticipatory planning and advanced simulation technologies will play an increasingly central role in delivering durable personalized care for patients with severe AS.
- 17 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2269
Open AccessLifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making
Background: The landscape surrounding aortic stenosis continues to evolve as transcatheter aortic valve replacement (TAVR) is increasingly performed in younger and lower-risk patients who are likely to outlive their index prosthesis. With the rapid evolution in management of aortic stenosis, treatment has shifted from a single-procedure paradigm toward a lifetime strategy that anticipates future reinterventions. Therefore, having a foundational understanding and a thoughtful strategy when selecting the index procedure is paramount. Objectives: The objectives of this review article are to review contemporary evidence and provide a structured framework for lifetime management of severe AS. We focus on optimizing index valve selection and planning durable, safe pathways for subsequent reinterventions. Conclusions: Lifetime management of aortic stenosis requires a forward-looking, patient-centered Heart Team approach that extends beyond immediate procedural success. Strategic selection of the index valve intervention is crucial, and this is guided by anatomy, life expectancy, comorbidities, patient preference, and future reintervention feasibility. Together, these factors are essential to optimize long-term outcomes. As treatment paradigms continue to evolve, anticipatory planning and advanced simulation technologies will play an increasingly central role in delivering durable personalized care for patients with severe AS.